IFNG and melanoma: Th1/IFNγ gene signature in the tumor microenvironment has been regarded as an independent biomarker to predict the prognosis of resectable high-risk melanoma patients.352 Moreover, the status of IFN-γ is associated with the response or resistance to immunotherapy.